Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-30 · accession 0000950170-25-080313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-02 | 2025-05-30 | CRBP | Kung Winston | Dir | A - Grant | $0.00 | +4,800 | 10.4K | +86% | $0 |
| D | 2025-06-02 | 2025-05-30 | CRBP | Kung Winston | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2025-05-30 | A | A | 4,800 | $0.00 | 10,366 | D | — | — | (F1) On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. (F2) This amount includes 10,366 unvested RSUs subject to each grant's vesting schedule as previously reported. |
| 2 | Derivative | Stock options (right to buy) | 2025-05-30 | A | A | 16,000 | $0.00 | 16,000 | D | $7.42 · — to 2035-05-30 | 16,000 Common Stock | (F3) The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant. |